The Emerging Therapeutic Targets for Scar Management: Genetic and Epigenetic Landscapes

被引:12
作者
Amjadian, Sara [2 ,3 ]
Moradi, Sharif [2 ]
Mohammadi, Parvaneh [1 ,2 ]
机构
[1] Univ Regensburg, Expt Med & Therapy Res, Regensburg, Germany
[2] Royan Inst Stem Cell Biol & Technol, Cell Sci Res Ctr, Dept Stem Cells & Dev Biol, ACECR, Tehran, Iran
[3] Univ Sci & Culture, Dept Dev Biol, Tehran, Iran
关键词
Wound healing; Hypertrophic scar; Scar-promoting genes; MicroRNA; Noncoding RNAs; GROWTH-FACTOR-BETA; NECROSIS-FACTOR-ALPHA; HYPERTROPHIC SCARS; EXTRACELLULAR-MATRIX; EPIDERMAL-KERATINOCYTES; I RECEPTOR; TGF-BETA; SKIN; EXPRESSION; FIBROBLASTS;
D O I
10.1159/000524990
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Wound healing is a complex process including hemostasis, inflammation, proliferation, and remodeling during which an orchestrated array of biological and molecular events occurs to promote skin regeneration. Abnormalities in each step of the wound healing process lead to reparative rather than regenerative responses, thereby driving the formation of cutaneous scar. Patients suffering from scars represent serious health problems such as contractures, functional and esthetic concerns as well as painful, thick, and itchy complications, which generally decrease the quality of life and impose high medical costs. Therefore, therapies reducing cutaneous scarring are necessary to improve patients' rehabilitation. Summary: Current approaches to remove scars, including surgical and nonsurgical methods, are not efficient enough, which is in principle due to our limited knowledge about underlying mechanisms of pathological as well as the physiological wound healing process. Thus, therapeutic interventions focused on basic science including genetic and epigenetic knowledge are recently taken into consideration as promising approaches for scar management since they have the potential to provide targeted therapies and improve the conventional treatments as well as present opportunities for combination therapy. In this review, we highlight the recent advances in skin regenerative medicine through genetic and epigenetic approaches to achieve novel insights for the development of safe, efficient, and reproducible therapies and discuss promising approaches for scar management. Key Message: Genetic and epigenetic regulatory switches are promising targets for scar management, provided the associated challenges are to be addressed.
引用
收藏
页码:247 / 265
页数:19
相关论文
共 157 条
[1]   Hypertrophic scar formation following burns and trauma: New approaches to treatment [J].
Aarabi, Shahram ;
Longaker, Michael T. ;
Gurtner, Geoffrey C. .
PLOS MEDICINE, 2007, 4 (09) :1464-1470
[2]   Adipose Tissue-Derived Mesenchymal Cells Support Skin Reepithelialization Through Secretion of KGF-1 and PDGF-BB: Comparison With Dermal Fibroblasts [J].
Alexaki, Vassilia-Ismini ;
Simantiraki, Despoina ;
Panayiotopoulou, Marianna ;
Rasouli, Olga ;
Venihaki, Maria ;
Castana, Ourania ;
Alexakis, Dimitrios ;
Kampa, Marilena ;
Stathopoulos, Efstathios N. ;
Castanas, Elias .
CELL TRANSPLANTATION, 2012, 21 (11) :2441-2454
[3]   Scar management in burn injuries using drug delivery and molecular signaling: Current treatments and future directions [J].
Amini-Nik, Saeid ;
Yousuf, Yusef ;
Jeschke, Marc G. .
ADVANCED DRUG DELIVERY REVIEWS, 2018, 123 :135-154
[4]   The Effects of Insulin-Like Growth Factor-1 Gene Therapy and Cell Transplantation on Rat Acute Wound Model [J].
Amiri, Fereshteh Talebpour ;
Fathabadi, Fatemeh Fadaei ;
Rad, Mahnaz Mahmoudi ;
Piryae, Abbas ;
Ghasemi, Azar ;
Khalilian, Alireza ;
Yeganeh, Farshid ;
Mosaffa, Nariman .
IRANIAN RED CRESCENT MEDICAL JOURNAL, 2014, 16 (10)
[5]  
Arakawa M, 1996, BRIT J DERMATOL, V134, P863
[6]   New molecular medicine-based scar management strategies [J].
Arno, Anna I. ;
Gauglitz, Gerd G. ;
Barret, Juan P. ;
Jeschke, Marc G. .
BURNS, 2014, 40 (04) :539-551
[7]   Tumor necrosis factor-alpha (TNF-a) is a therapeutic target for impaired cutaneous wound healing [J].
Ashcroft, Gillian S. ;
Jeong, Moon-Jin ;
Ashworth, Jason J. ;
Hardman, Matthew ;
Jin, Wenwen ;
Moutsopoulos, Niki ;
Wild, Teresa ;
McCartney-Francis, Nancy ;
Sim, Davis ;
McGrady, George ;
Song, Xiao-yu ;
Wahl, Sharon M. .
WOUND REPAIR AND REGENERATION, 2012, 20 (01) :38-49
[8]  
Atiyeh B S, 2013, Ann Burns Fire Disasters, V26, P205
[9]   Identification of sirtuin 1 as a promising therapeutic target for hypertrophic scars [J].
Bai, Xiao-Zhi ;
Liu, Jia-Qi ;
Yang, Long-Long ;
Fan, Lei ;
He, Ting ;
Su, Lin-Lin ;
Shi, Ji-Hong ;
Tang, Chao-Wu ;
Zheng, Zhao ;
Hu, Da-Hai .
BRITISH JOURNAL OF PHARMACOLOGY, 2016, 173 (10) :1589-1601
[10]   Adenoviral-mediated gene transfer of insulin-like growth factor 1 enhances wound healing and induces angiogenesis [J].
Balaji, Swathi ;
LeSaint, Maria ;
Bhattacharya, Sukanta S. ;
Moles, Chad ;
Dhamija, Yashu ;
Kidd, Mykia ;
Le, Louis D. ;
King, Alice ;
Shaaban, Aimen ;
Crombleholme, Timothy M. ;
Bollyky, Paul ;
Keswani, Sundeep G. .
JOURNAL OF SURGICAL RESEARCH, 2014, 190 (01) :367-377